Health
Common diabetes drug can reduce risk of major heart issues – TheHealthSite
SGLT2 inhibitors prescribed for diabetes can reduce the risk of heart conditions such as heart attack stroke and heart failure compared with placebo.
Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers. According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo. But some of these trials had important limitations, making it…
-
Noosa News18 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
General23 hours agoNew Spirit of Tasmania ferry arrives in Hobart, but will not be operating for more than a year
-
Noosa News23 hours agoScientists move precious ReefHQ coral ahead of Great Barrier Reef Aquarium build
-
General24 hours agoWA government is ‘spinning’ the results of community survey into Burswood Park racetrack and community hub, locals say